Project Description
Based on preliminary results that showed that the specific fusion protein (NPM-RAR) inhibits differentiation of myeloid cells, Dr. Redner continued his investigations into the mechanism whereby NPM-RAR might alter vitamin A signaling and may compete with retinoic acid receptors for binding to a family of proteins which are essential to retinoic acid receptor function.